User profiles for Petur B. Juliusson
Petur JuliussonVerified email at fhi.no Cited by 4804 |
Growth references for 0–19 year-old Norwegian children for length/height, weight, body mass index and head circumference
PB Júlíusson, M Roelants, E Nordal… - Annals of human …, 2013 - Taylor & Francis
Background: Previous growth references for Norwegian children were based on measurements
from the 1970s and 1980s. New reference data, collected through the Bergen Growth …
from the 1970s and 1980s. New reference data, collected through the Bergen Growth …
Feeding problems, growth and nutritional status in children with cerebral palsy
MO Dahlseng, AK Finbråten, PB Júlíusson… - Acta …, 2012 - Wiley Online Library
Aim: The aim was to estimate the prevalence of feeding and nutritional problems in children
with cerebral palsy (CP) in Norway. Methods: Data were abstracted from the Norwegian CP …
with cerebral palsy (CP) in Norway. Methods: Data were abstracted from the Norwegian CP …
Growth of Belgian and Norwegian children compared to the WHO growth standards: prevalence below− 2 and above+ 2 SD and the effect of breastfeeding
PB Júlíusson, M Roelants… - Archives of disease in …, 2011 - adc.bmj.com
Background New national growth references have been published in Belgium and Norway.
The WHO recommends universal use of their 2006 Child Growth Standards based on data …
The WHO recommends universal use of their 2006 Child Growth Standards based on data …
[HTML][HTML] Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
…, E Codner, EH Tessmann, PB Juliusson… - The lancet Diabetes & …, 2018 - thelancet.com
Background KCNJ11 mutations cause permanent neonatal diabetes through pancreatic
ATP-sensitive potassium channel activation. 90% of patients successfully transfer from insulin to …
ATP-sensitive potassium channel activation. 90% of patients successfully transfer from insulin to …
[HTML][HTML] Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry
…, J Molnes, P Sztromwasser, I Aukrust, PB Juliusson… - Diabetologia, 2017 - Springer
Aims/hypothesis MODY can be wrongly diagnosed as type 1 diabetes in children. We aimed
to find the prevalence of MODY in a nationwide population-based registry of childhood …
to find the prevalence of MODY in a nationwide population-based registry of childhood …
Overweight and obesity in Norwegian children: prevalence and socio‐demographic risk factors
PB Júlíusson, GE Eide, M Roelants, PE Waaler… - Acta …, 2010 - Wiley Online Library
Aim: The aim of this study was to estimate the prevalence of childhood overweight and obesity
and to identify socio‐demographic risk factors in Norwegian children. Methods: The body …
and to identify socio‐demographic risk factors in Norwegian children. Methods: The body …
[HTML][HTML] Growth charts for Norwegian children
PB Júlíusson, M Roelants, GE Eide… - Tidsskrift for Den …, 2009 - tidsskriftet.no
Background. Background. The growth charts currently used in Norway, are based on
measurements from the 1970s and 80s. New data, collected in 2003–06, are available from the …
measurements from the 1970s and 80s. New data, collected in 2003–06, are available from the …
Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs
LGE Hanem, S Stridsklev, PB Júlíusson… - The Journal of …, 2018 - academic.oup.com
… Pétur B Júlíusson , Pétur B Júlíusson … To counteract possible metformin effects on folate
or vitamin B levels, the participants were advised to take 0.8 mg folate and one multivitamin …
or vitamin B levels, the participants were advised to take 0.8 mg folate and one multivitamin …
Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5–10 year follow-up of the PregMet randomised controlled trial
LGE Hanem, Ø Salvesen, PB Juliusson… - The Lancet Child & …, 2019 - thelancet.com
Background Metformin is increasingly used to treat gestational diabetes and type 2 diabetes
in pregnancy, and in attempts to improve pregnancy outcomes in polycystic ovary syndrome …
in pregnancy, and in attempts to improve pregnancy outcomes in polycystic ovary syndrome …
[HTML][HTML] Timing of menarche in Norwegian girls: associations with body mass index, waist circumference and skinfold thickness
Background Research studies show conflicting results regarding the association between
menarche and body weight. The purpose of the present study was to investigate if …
menarche and body weight. The purpose of the present study was to investigate if …